ImmuCell Corporation (ICCC)
NASDAQ: ICCC
· Real-Time Price · USD
5.33
-0.09 (-1.66%)
At close: May 01, 2025, 3:24 PM
5.30
-0.56%
After-hours: May 01, 2025, 04:05 PM EDT
ImmuCell Revenue
ImmuCell reported an annual revenue of $26.49M, reflecting a 51.64% growth. For the quarter ending December 31, 2024, ImmuCell generated $7.75M in revenue.
Revenue (ttm)
$26.49M
Revenue Growth
51.64%
Price / Sales Ratio
1.59
Revenue / Employee
$383.96K
Employees
69
Market Cap
47.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 26.49M | +51.64% |
| Dec 31, 2023 | 17.47M | -5.90% |
| Dec 31, 2022 | 18.57M | -3.51% |
| Dec 31, 2021 | 19.24M | +25.43% |
| Dec 31, 2020 | 15.34M | n/a |